Related Experiment Video
Updated: Aug 5, 2026
05:59
High-Throughput Small Molecule Drug Screening For Age-Related Sleep Disorders Using Drosophila melanogaster
Published on: October 20, 2023
Summary
This article outlines evaluating, diagnosing, and managing hypersomnia disorders. New treatments like extended-release sodium oxybate and orexin receptor 2 agonists offer improved options for excessive daytime sleepiness.
Area of Science:
- Neurology
- Sleep Medicine
- Pharmacology
Background:
- Hypersomnia disorders are characterized by excessive daytime sleepiness.
- Sleepiness can stem from primary sleep disorders or secondary conditions.
- Accurate diagnosis is crucial but challenging due to imperfect diagnostic tools.
Purpose of the Study:
- To provide a comprehensive overview of hypersomnia disorder evaluation.
- To detail diagnostic approaches for hypersomnia.
- To outline management strategies for patients with hypersomnia.
Main Methods:
- Detailed sleep history is essential for understanding symptom impact.
- Diagnostic tools, while useful, have limitations.
- Cerebrospinal fluid (CSF) orexin testing aids in diagnosing narcolepsy type 1.
Main Results:
- An extended-release formulation of sodium oxybate was approved for narcolepsy treatment.
- This new formulation may enhance medication adherence and reduce sleep disruption.
- Orexin receptor 2 agonists are under investigation for narcolepsy and idiopathic hypersomnia.
Conclusions:
- Effective evaluation, diagnosis, and management of hypersomnia are critical.
- Recent advancements include novel pharmacologic treatments for narcolepsy.
- Ongoing research into orexin agonists shows promise for treating hypersomnia disorders.
Related Concept Videos
01:07Narcolepsy
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
01:19Management of Insomnia
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
01:24Sleep-Wake Cycles
Sleep is an essential physiological process vital to maintaining overall well-being. The reticular activating system (RAS), a network of neurons in the brainstem, regulates wakefulness and sleep. While it may seem passive, sleep consists of distinct cycles, each with its unique characteristics and functions. Two key sleep phases are non-rapid eye movement (NREM) and rapid eye movement (REM).
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
NREM Sleep
NREM sleep comprises four progressive stages that seamlessly merge:
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:27Insomnia
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
01:17Sleepwalking and Sleep Talking
Somnambulism, commonly known as sleepwalking, involves individuals engaging in activities ranging from simple walking to more complex behaviors such as driving. Sleepwalking typically occurs during the slow-wave sleep stages 3 and 4 early in the night when the person is not dreaming, contradicting the myth that sleepwalkers are acting out their dreams.
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...
Factors that increase the likelihood of sleepwalking include sleep deprivation and alcohol consumption. Contrary to common beliefs, it is safe...